Skip to content

Supplier News

Freeman Beauty appoints George CEO

Freeman Beauty appoints George CEO

Freeman Beauty announced the appointment of Bill George as the company’s new chief executive officer. Following the success of April’s first National Face Mask Month, George will join the company immediately following his previous post at Markwins Beauty Brands.

RangeMe grows to over 125,000 SMB suppliers

RangeMe grows to over 125,000 SMB suppliers

RangeMe, the award-winning online platform that streamlines new product discovery between product suppliers and retailers, has eclipsed more than 125,000 suppliers on its platform. This staggering number represents massive growth for the company over the past two years.

Mylan and WVU join forces to inspire STEM-CARE

Mylan and WVU join forces to inspire STEM-CARE

Global pharmaceutical company Mylan and West Virginia University (WVU) today announced a 10-year collaboration, supported by a $5 million charitable contribution from Mylan, to develop and implement a program that will expose children across West Virginia to STEM (Science, Technology, Engineering an

Hawaiian Tropic rolls out new sun care products

Hawaiian Tropic rolls out new sun care products

Hawaiian Tropic has upped the game for total-body sun care by releasing Hawaiian Tropic Antioxidant Plus and new Silk Hydration Weightless After Sun. Together, the products provide benefits for during and after sun exposure, while leaving skin feeling nourished.

Executive leadership changes at Kimberly-Clark

Executive leadership changes at Kimberly-Clark

Kimberly-Clark  announced executive leadership changes to sharpen its focus on executing its global business plan. Kim Underhill, president of Kimberly-Clark Professional, has been named group president Kimberly-Clark North America.

Novartis announces FDA approval of Gilenya

Novartis announces FDA approval of Gilenya

Novartis announced that the U.S. Food and Drug Administration (FDA) has approved Gilenya (fingolimod) for the treatment of children and adolescents 10 to less than 18 years of age with relapsing forms of multiple sclerosis, making it the first disease-modifying therapy indicated for these patients.

PANTHERx selected by Otsuka to distribute Jynarque

PANTHERx selected by Otsuka to distribute Jynarque

PANTHERx Specialty Pharmacy has been selected by Otsuka America Pharmaceutical, Inc.  to distribute Jynarque (tolvaptan), the only FDA-approved therapy for patients diagnosed with autosomal dominant polycystic kidney disease (ADPKD).